ASX Announcement Page | 1 8 October, 2026 Melbourne, Australia Update on U.S. Plasma Collection Network CSL Limited (ASX:CSL; USOTC:CSLLY) today announces an expansion of its relationship with Haemonetics Corporation. CSL expects to have completed the rollout of Haemonetics’ latest generation...
Update on U.S. Plasma Collection Network
Filed with ASX · · 1 page · English
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings CallRelease
Earlier from CSL
- CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
- CSL prices US$1.5 billion in Corporate Bonds
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
- CSL enters exclusive agreement with Alentis Therapeutics
Later from CSL
- Appointment of New CEO
- CSL appoints Deborah Waterhouse as CEO & Managing Director
- CSL to Defend Class Action
- Brian McNamee to retire Gordon Naylor appointed next Chair
- CSL Limited Annual General Meeting 2026
Follow CSL into a list and get an email when it puts out news.
Follow CSL